Osiris Therapeutics, Inc. , the leading company focused on developing and marketing stem cell products to treat serious medical conditions, announced today the successful conclusion of a patent challenge in Australia by an opponent whose identity under Australian law was not disclosed.
http://technews.tmcnet.com/news/2013/02/18/6930319.htm
http://technews.tmcnet.com/news/2013/02/18/6930319.htm
No comments:
Post a Comment